Does quality of care for cardiovascular disease and diabetes differ by gender for enrollees in managed care plans?
PURPOSE: To assess gender differences in the quality of care for cardiovascular disease and diabetes for enrollees in managed care plans. METHODS: We obtained data from 10 commercial and 9 Medicare plans and calculated performance on 6 Health Employer Data and Information Set (HEDIS) measures of quality of care (beta-blocker use after myocardial infarction [MI], low-density lipoprotein cholesterol [LDL-C] check after a cardiac event, and in diabetics, whether glycosylated hemoglobin [HgbA1c], LDL cholesterol, nephropathy, and eyes were checked) and a 7th HEDIS-like measure (angiotensin-converting enzyme [ACE] inhibitor use for congestive heart failure). A smaller number of plans provided HEDIS scores on 4 additional measures that require medical chart abstraction (control of LDL-C after cardiac event, blood pressure control in hypertensive patients, and HgbA1c and LDL-C control in diabetics). We used logistic regression models to adjust for age, race/ethnicity, socioeconomic status, an
Related Questions
- Does quality of care for cardiovascular disease and diabetes differ by gender for enrollees in managed care plans?
- How does the Oxford Freedom Plan differ from conventional health Insurance plans and other managed care plans?
- Do Physician and Patient Gender Affect how Cardiovascular Disease Risk Factors are Managed in Primary Care?
